ArticleJournal of thoracic disease2025
Contrast-enhanced computed tomography-based intratumoral and peritumoral radiomics for identifying malignancy in pulmonary ground-glass nodules.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advancing lung adenocarcinoma diagnosis using peri-nodular features: a CT radiomics study for determining invasiveness in sub-centimeter pure ground glass nodules.Journal of thoracic disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung cancer remains the leading cause of cancer-related deaths worldwide. Early-stage lung cancer often presents as ground-glass nodules (GGNs) on computed tomography (CT). However, reliably distinguishing benign from malignant GGNs using conventional morphological features on CT remains a significant challenge, which impedes the accuracy of clinical surgical decision-making. Against this backdrop, radiomics, a technique that extracts quantitative features from medical images, offers a promising solution. This study aimed to investigate the predictive value of machine learning models based on radiomic features from intratumoral and peritumoral regions on contrast-enhanced CT in differentiating benign and malignant GGNs preoperatively. Methods: This retrospective study included 147 patients with pathologically confirmed GGNs who underwent contrast-enhanced CT before surgical resection between 2019 and 2023. Patients were randomly divided into a training set and a test set at a 7:3 ratio. Radiomics feature selection was performed using the minimum redundancy maximum relevance (mRMR) method followed by least absolute shrinkage and selection operator (LASSO) regression. Intratumoral and peritumoral models were built separately. Clinical features were selected via univariate and multivariate logistic regression analyses to construct a clinical model. An integrated radiomics-clinical model was then developed. Model performance was assessed using receiver operating characteristic (ROC) curves, sensitivity, specificity, calibration curves, and decision curve analysis (DCA). Results: Of the 147 patients, 87 had malignant and 60 had benign GGNs. The combined clinical-intratumoral model demonstrated the best diagnostic performance, with area under the ROC curve (AUC) values of 0.870 in both the training and test sets. The sensitivities were 0.787 and 0.654, and the specificities were 0.833 and 0.889, respectively. Conclusions: The intratumoral radiomics features based on enhanced CT, especially when combined with clinical features, have a high predictive value for the preoperative diagnosis of the benign and malignant nature of GGNs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.